Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors From September 7, 2020, to February 27, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback